A Phase 2 Study of BNC210 for the Acute Treatment of Social Anxiety Disorder

Clinical trial NCT05193409 · COMPLETED

Trial details

NCT number: NCT05193409
Sponsor: Bionomics Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Social Anxiety Disorder

Start date: 2022-02-02
Primary completion: 2022-10-10
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.